623 related articles for article (PubMed ID: 30209206)
1. CRISPR-Cas immunity, DNA repair and genome stability.
Cubbon A; Ivancic-Bace I; Bolt EL
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
[TBL] [Abstract][Full Text] [Related]
2. Antisense RNA Interference-Enhanced CRISPR/Cas9 Base Editing Method for Improving Base Editing Efficiency in
Zhang Y; Yun K; Huang H; Tu R; Hua E; Wang M
ACS Synth Biol; 2021 May; 10(5):1053-1063. PubMed ID: 33720688
[TBL] [Abstract][Full Text] [Related]
3. Gene Editing With TALEN and CRISPR/Cas in Rice.
Bi H; Yang B
Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
[TBL] [Abstract][Full Text] [Related]
4. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
Elife; 2021 Dec; 10():. PubMed ID: 34898428
[TBL] [Abstract][Full Text] [Related]
5. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
Zhou Y; Zong Y; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
[TBL] [Abstract][Full Text] [Related]
6. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
7. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
Zhang Y; Huang H; Zhang B; Lin S
Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
Xu Z; Li Y; Li M; Xiang H; Yan A
Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9; an efficient tool for precise plant genome editing.
Islam W
Mol Cell Probes; 2018 Jun; 39():47-52. PubMed ID: 29621557
[TBL] [Abstract][Full Text] [Related]
10. Unbiased investigation of specificities of prime editing systems in human cells.
Kim DY; Moon SB; Ko JH; Kim YS; Kim D
Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
[TBL] [Abstract][Full Text] [Related]
11. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
[TBL] [Abstract][Full Text] [Related]
12. The origin of unwanted editing byproducts in gene editing.
Yin J; Hu J
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(6):767-781. PubMed ID: 35643959
[TBL] [Abstract][Full Text] [Related]
13. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
Shen J; Zhou J; Chen GQ; Xiu ZL
J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
[No Abstract] [Full Text] [Related]
14. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the potential of CRISPR-Cas9 for gene therapy.
Barrangou R; May AP
Expert Opin Biol Ther; 2015 Mar; 15(3):311-4. PubMed ID: 25535790
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria.
Bernheim A; Calvo-Villamañán A; Basier C; Cui L; Rocha EPC; Touchon M; Bikard D
Nat Commun; 2017 Dec; 8(1):2094. PubMed ID: 29234047
[TBL] [Abstract][Full Text] [Related]
17. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
Naduthodi MIS; Barbosa MJ; van der Oost J
Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks.
Brinkman EK; Chen T; de Haas M; Holland HA; Akhtar W; van Steensel B
Mol Cell; 2018 Jun; 70(5):801-813.e6. PubMed ID: 29804829
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
20. Diversity of CRISPR-Cas-Mediated Mechanisms of Adaptive Immunity in Prokaryotes and Their Application in Biotechnology.
Savitskaya EE; Musharova OS; Severinov KV
Biochemistry (Mosc); 2016 Jul; 81(7):653-61. PubMed ID: 27449612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
